Literature DB >> 17954701

Bile and unsaturated fatty acids inhibit the binding of cholera toxin and Escherichia coli heat-labile enterotoxin to GM1 receptor.

Arpita Chatterjee1, Rukhsana Chowdhury.   

Abstract

Cholera toxin (CT) is an archetypal bacterial toxin that binds with a high affinity to the receptor ganglioside GM1 on the intestinal epithelial surface and that causes the severe watery diarrhea characteristic of the disease cholera. Blockage of the interaction of CT with the GM1 receptor is an attractive approach for therapeutic intervention. We report here that crude bile prevents the interaction of CT with GM1 and reduces CT-mediated fluid accumulation in the rabbit intestine. The unsaturated fatty acids detected in crude bile, arachidonic, linoleic, and oleic acids, were found to be the most effective. Crude bile and the unsaturated fatty acids interacted with CT but not GM1 to prevent CT-GM1 binding. Neither crude bile nor the unsaturated fatty acids had any effect on the subunit structure of CT. The binding of CT to unsaturated fatty acids resulted in a shift of the apparent pI of CT from 6.8 to 8.2 and a marked decrease in intrinsic fluorescence. The Kd was calculated from fluorescence quenching assays. It was demonstrated by the rabbit ileal loop model that practically no fluid accumulated in the intestinal loops when CT was administered together with inhibitory concentrations of linoleic acid. The bile present in the intestine was sufficient to inhibit the activity of up to 300 ng CT. Bile and unsaturated fatty acids also inhibited the binding of Escherichia coli heat-labile enterotoxin (LT) to GM1, and no fluid accumulation was observed in rabbit ileal loops when LT was administered together with linoleic acid.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17954701      PMCID: PMC2223916          DOI: 10.1128/AAC.01009-07

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  14 in total

1.  Diarrheal diseases in the history of public health.

Authors:  Nguendo Yongsi Hénock Blaise; Delali B K Dovie
Journal:  Arch Med Res       Date:  2007-02       Impact factor: 2.235

2.  Structural and functional studies of Saccharomyces cerevisiae myristoyl-CoA:protein N-myristoyltransferase produced in Escherichia coli. Evidence for an acyl-enzyme intermediate.

Authors:  D A Rudnick; C A McWherter; S P Adams; I J Ropson; R J Duronio; J I Gordon
Journal:  J Biol Chem       Date:  1990-08-05       Impact factor: 5.157

3.  Deactivation of cholera toxin by a sialidase-resistant monosialosylganglioside.

Authors:  C A King; W E Van Heyningen
Journal:  J Infect Dis       Date:  1973-06       Impact factor: 5.226

4.  Dissociation and recombination of the subunits of the cholera enterotoxin (choleragen).

Authors:  R A Finkelstein; M Boesman; S H Neoh; M K LaRue; R Delaney
Journal:  J Immunol       Date:  1974-07       Impact factor: 5.422

5.  Multiply antibiotic-resistant Vibrio cholerae O1 biotype El Tor strains emerge during cholera outbreaks in Zambia.

Authors:  J C L Mwansa; J Mwaba; C Lukwesa; N A Bhuiyan; M Ansaruzzaman; T Ramamurthy; M Alam; G Balakrish Nair
Journal:  Epidemiol Infect       Date:  2006-11-23       Impact factor: 2.451

6.  3,5-Substituted phenyl galactosides as leads in designing effective cholera toxin antagonists; synthesis and crystallographic studies.

Authors:  Daniel D Mitchell; Jason C Pickens; Konstantin Korotkov; Erkang Fan; Wim G J Hol
Journal:  Bioorg Med Chem       Date:  2004-03-01       Impact factor: 3.641

7.  Structure-based exploration of the ganglioside GM1 binding sites of Escherichia coli heat-labile enterotoxin and cholera toxin for the discovery of receptor antagonists.

Authors:  W E Minke; C Roach; W G Hol; C L Verlinde
Journal:  Biochemistry       Date:  1999-05-04       Impact factor: 3.162

8.  Antibiotic resistance of gram-negative bacteria in rivers, United States.

Authors:  Ronald J Ash; Brena Mauck; Melissa Morgan
Journal:  Emerg Infect Dis       Date:  2002-07       Impact factor: 6.883

Review 9.  Mechanism of action of cholera toxin & other toxins.

Authors:  N K Ganguly; T Kaur
Journal:  Indian J Med Res       Date:  1996-07       Impact factor: 2.375

10.  Immunological relationships between cholera toxin and Escherichia coli heat-labile enterotoxin.

Authors:  P H Gilligan; J C Brown; D C Robertson
Journal:  Infect Immun       Date:  1983-11       Impact factor: 3.441

View more
  5 in total

1.  A fadD mutant of Vibrio cholerae is impaired in the production of virulence factors and membrane localization of the virulence regulatory protein TcpP.

Authors:  Sreejana Ray; Epshita Chatterjee; Arpita Chatterjee; Kalidas Paul; Rukhsana Chowdhury
Journal:  Infect Immun       Date:  2010-11-01       Impact factor: 3.441

Review 2.  Survival of the Fittest: How Bacterial Pathogens Utilize Bile To Enhance Infection.

Authors:  Jeticia R Sistrunk; Kourtney P Nickerson; Rachael B Chanin; David A Rasko; Christina S Faherty
Journal:  Clin Microbiol Rev       Date:  2016-10       Impact factor: 26.132

Review 3.  Heat-labile enterotoxin: beyond G(m1) binding.

Authors:  Benjamin Mudrak; Meta J Kuehn
Journal:  Toxins (Basel)       Date:  2010-06-14       Impact factor: 4.546

Review 4.  Enterotoxigenic Escherichia coli: intestinal pathogenesis mechanisms and colonization resistance by gut microbiota.

Authors:  Yucheng Zhang; Peng Tan; Ying Zhao; Xi Ma
Journal:  Gut Microbes       Date:  2022 Jan-Dec

5.  Bioactive Compound Produced by Endophytic Fungi Isolated From Pelargonium sidoides Against Selected Bacteria of Clinical Importance.

Authors:  Madira Coutlyne Manganyi; Christ-Donald K Tchatchouang; Thierry Regnier; Cornelius Carlos Bezuidenhout; Collins Njie Ateba
Journal:  Mycobiology       Date:  2019-07-04       Impact factor: 1.858

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.